West Pharmaceutical Services, Inc. — News

While the top- and bottom-line numbers for West Pharmaceutical (WST) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-07-23 10:31:14

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $1.84 per share a year ago.

zacks.com - 2026-07-23 08:16:06

West Pharmaceutical Services raised its annual profit and revenue forecasts on Thursday as strong demand for components used ​in injectable drugs, including diabetes and obesity treatments, ‌helped it beat second-quarter estimates.

reuters.com - 2026-07-23 06:33:31

Raising Full-Year Net Sales and EPS guidance EXTON, Pa., July 23, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.

prnewswire.com - 2026-07-23 06:00:00

Andra AP fonden grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 723.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 55,007 shares of the medical instruments supplier's stock after buying an additional 48,327 shares during the period. Andra AP fonden

defenseworld.net - 2026-07-22 03:45:54

EXTON, Pa., July 21, 2026 /PRNewswire/ -- On July 21, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on August 5, 2026 to shareholders of record on July 29, 2026.

prnewswire.com - 2026-07-21 16:00:00

WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.

zacks.com - 2026-07-21 12:36:06

Besides Wall Street's top-and-bottom-line estimates for West Pharmaceutical (WST), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

zacks.com - 2026-07-21 10:16:12

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-07-20 12:41:03

West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-07-16 11:06:37

West Pharmaceutical Services, Inc.  WST is well positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug programs and regulatory-driven Annex 1 conversions. However, tariff impacts, destocking in generics and execution challenges at constrained European facilities are concerning.

zacks.com - 2026-07-15 13:10:45

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

zacks.com - 2026-07-14 04:36:12

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.

zacks.com - 2026-07-13 13:40:24

West Pharmaceutical completes the SmartDose 3.5mL sale to AbbVie, sharpening its focus on higher-growth on-body drug delivery technologies.

zacks.com - 2026-07-09 10:01:25

I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Year-to-date through June, the investable universe returned 8.69%, trailing SPY (10.10%) and SCHD (17.50%), but several individual stocks outperformed significantly. Currently, 39 out of 50 stocks offer a forward return estimate of at least 10%, with 22 appearing potentially undervalued by my free cash flow model.

seekingalpha.com - 2026-07-08 07:42:40

Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.

zacks.com - 2026-07-07 13:01:20

EXTON, Pa., July 7, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2026 financial results before the market opens on Thursday, July 23, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.

prnewswire.com - 2026-07-07 06:00:00

WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.

zacks.com - 2026-07-03 14:46:10

EXTON, Pa., July 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the company completed the sale and transfer of the manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities. The transaction closed as planned on July 1, 2026.

prnewswire.com - 2026-07-01 16:30:00

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Merit Medical (MMSI) and West Pharmaceutical Services (WST). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com - 2026-07-01 12:40:34

Pre-Market Stock Futures: Futures are trading higher after the bulls tried to rally stocks on Monday, after the drubbing they took on Friday, and it looks the same way today. While it was a partial victory on Monday, by the close, the huge gains from the morning were cut in half, and the Dow Jones... Here Are Tuesday's Top Wall Street Analyst Research Calls: Cerebras Systems, Cleveland-Cliffs, Equity Residential, FuelCell Energy, Lennar, Luckin Coffee, Toll Brothers, and More

247wallst.com - 2026-06-09 07:58:00

I track a curated universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and forward return potential. Year-to-date, the universe lags SPY and SCHD, but select names like LRCX (+343%) and KLAC (+208%) have dramatically outperformed since inception. Currently, 40 stocks offer forward return estimates of at least 10%, with 24 appearing potentially undervalued by my free cash flow model.

seekingalpha.com - 2026-06-08 04:51:11

West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript

seekingalpha.com - 2026-06-02 19:11:53

The Microsoft founder's foundation recently added this healthcare stock to its portfolio.

fool.com - 2026-06-02 18:30:00

West Pharmaceutical said on Monday it appointed former Thermo Fisher Scientific executive Michel ​Lagarde as its top boss, effective ‌August 31, succeeding longtime chief Eric Green.

reuters.com - 2026-06-01 17:21:55

Experienced healthcare and life sciences executive to lead the Company's next phase of growth and innovation EXTON, Pa., June 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Board of Directors has appointed Michel Lagarde to be President and Chief Executive Officer (CEO) and a member of the Company's Board of Directors starting August 31, 2026.

prnewswire.com - 2026-06-01 16:30:00

On May 21, 2026, West Pharmaceutical Services Inc (WST) shares rose 3.5% to $316.13. This uptick comes amidst a positive price performance, with shares having t

gurufocus.com - 2026-05-21 18:03:00

West Pharmaceutical Services, Inc.  WST is well positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug programs and regulatory-driven Annex 1 conversions. However, tariff impacts, destocking in generics and execution challenges at constrained European facilities are concerning.

zacks.com - 2026-05-21 09:56:18

West Pharmaceutical Services said on Wednesday it has ​restored operations across its sites after a cybersecurity attack earlier this ‌month and expects the incident to have no material impact on its 2026 financial outlook.

reuters.com - 2026-05-20 17:24:42

West Pharmaceutical Services said on Friday its operations were steadily recovering after a cyberattack ​earlier this month disrupted manufacturing and logistics ‌globally.

reuters.com - 2026-05-15 14:17:56

West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-12 21:10:43

West Pharmaceutical Services Inc. (NYSE:WST) on Monday disclosed a material cybersecurity attack on May 7, saying an unauthorized party exfiltrated data and encrypted certain systems.

benzinga.com - 2026-05-12 13:59:04

Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com - 2026-05-11 12:41:15

West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.com - 2026-05-11 10:16:33

From a technical perspective, West Pharmaceutical Services, Inc. (WST) is looking like an interesting pick, as it just reached a key level of support. WST's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

zacks.com - 2026-05-07 10:55:30

West Pharmaceutical Services maintains dominant market share in injectable drug delivery, underpinned by a wide moat and robust regulatory positioning. WST reported strong Q1 2026 results, with revenue up 21% and adjusted EPS up 46.9%, prompting a guidance raise and share price rebound. Key growth drivers include biologics market expansion, GLP-1 drug demand, and Annex 1 regulatory upgrades, supporting recurring revenue and margin strength.

seekingalpha.com - 2026-04-30 18:41:08

Comerica Bank boosted its holdings in West Pharmaceutical Services, Inc. (NYSE: WST) by 31.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 56,693 shares of the medical instruments supplier's stock after acquiring an additional 13,680 shares during the period.

defenseworld.net - 2026-04-29 14:23:21

Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.

zacks.com - 2026-04-29 13:00:51

West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

zacks.com - 2026-04-29 13:00:30

FIX, DVN and WST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 29th, 2026.

zacks.com - 2026-04-29 11:15:56

West Pharmaceutical Services (NYSE: WST | WST Price Prediction) has ripped 24.2% in the past month and 8.7% in the past week, and the move has the fingerprints of a sustained re-rating.

247wallst.com - 2026-04-28 08:15:52

EXTON, Pa., April 28, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: Bank of America Global Healthcare Conference on Tuesday, May 12, 2026 at 2:20 p.m. PDT in Las Vegas, NV William Blair Annual Growth Stock Conference on Tuesday, June 2, 2026 at 4:00 p.m.

prnewswire.com - 2026-04-28 06:00:00

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-04-27 10:46:51

Shares of West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report) have received an average rating of "Moderate Buy" from the twelve ratings firms that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has given a

defenseworld.net - 2026-04-27 02:22:50

HB Wealth Management LLC decreased its position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 27.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,850 shares of the medical instruments supplier's stock after selling 3,325 shares during the

defenseworld.net - 2026-04-26 04:00:54

West Pharmaceutical Services delivered a beat-and-raise 1Q26, with adjusted EPS of $2.13 and revenue of $844.9M, both well ahead of expectations. WST's growth is driven by robust demand for High-Value Product components, biologics, and a favorable mix shift, supporting margin expansion and durable earnings momentum. Management raised FY26 guidance to $3.35B revenue and $8.75 adjusted EPS, reflecting operational strength but maintaining a conservative outlook amid macro uncertainties.

seekingalpha.com - 2026-04-24 08:19:43

West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the company's first-quarter 2026 earnings surpassed analyst estimates.

benzinga.com - 2026-04-23 13:42:19

West Pharmaceutical posts 46.9% EPS growth and beats estimates as strong segment demand lifts revenues, prompting a higher 2026 outlook and margin expansion.

zacks.com - 2026-04-23 13:36:14

West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-23 12:01:38

The headline numbers for West Pharmaceutical (WST) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com - 2026-04-23 10:31:23